TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan
· Delayed Price · Currency is TWD 10.75
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST
TPEX:4157 Revenue
In the year 2024, TaiGen Biopharmaceuticals Holdings had annual revenue of 150.65M TWD with 22.35% growth. TaiGen Biopharmaceuticals Holdings had revenue of 10.49M in the quarter ending December 31, 2024, with 22.08% growth.
Revenue
150.65M
Revenue Growth
+22.35%
P/S Ratio
51.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 150.65M | 27.52M | 22.35% |
| Dec 31, 2023 | 123.13M | 86.90M | 239.87% |
| Dec 31, 2022 | 36.23M | -1.26B | -97.20% |
| Dec 31, 2021 | 1.29B | 1.27B | 5,426.95% |
| Dec 31, 2020 | 23.42M | 3.11M | 15.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |